FDA Clearance Tracker · P200041
Scoreflex NC Scoring PTCA Catheter
Last checked: Nov 19, 2026Latest source record: Dec 21, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Dec 21, 2021
Approved
Time to decision
468 days
Received Sep 9, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P200041
- Device name
- Scoreflex NC Scoring PTCA Catheter
- Applicant location
- Shenzhen
- Received
- Sep 9, 2020
- Decided
- Dec 21, 2021
- Decision
- Approved
- Supplements
- 9 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the Scoreflex NC Scoring PTCA Catheter. The device is indicated for: Balloon dilatation of a de novo stenotic portion of a coronary artery and in-stent restenosis in coronary arteries in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NWX. The earliest in FDA's data is P950020, decided Apr 18, 2000.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for OrbusNeich Medical (Shenzhen) Co., Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261778 · Decided Sep 16, 2026 · 110 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
K253361 · Decided Apr 10, 2026 · 192 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
K242588 · Decided Jan 7, 2025 · 130 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.